Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - moxidectin; black disease - clostridium novyi type b; blackleg = clostridium chauvoei; malignant oedema = clostridium septicum; cla = corynebacterium pseudotuberculosis ovis; clostridium perfringens type d toxoid; clostridium tetani - toxoid - misc. vaccines or anti sera - moxidectin anthelmintic active 2.5 g/l; black disease - clostridium novyi type b vaccine active 0.0 p; blackleg = clostridium chauvoei vaccine-microbial active 0.0 p; malignant oedema = clostridium septicum vaccine-microbial active 0.0 p; cla = corynebacterium pseudotuberculosis ovis vaccine-microbial active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p - parasiticides - lamb | sheep - weaner | ovine - barber's pole worm-haemonchus contortus | black disease | black scour worm - trichostrongylus spp. | blackleg | brown stomach worm - ostertagia lyrata | cheesy gland | cooperia curticei | cooperia oncophora | enterotoxaemia (pulpy kidney) | intestinal hair worm - t. colubriformis | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - dictyocaulus filaria | large mouthed bowel worm | malignant oedema | nasal bot | nematodirus abnormalis | nematodirus battus | nematodirus filicollis | nematodirus helvetianus | nodule worm - o. columbianum | ostertagia circumcincta | ostertagia trifurcata | sheep itch mite | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tetanus | thin necked intestinal worm | thin necked intestinal worm-n. spathiger | trichostrongylus rugatus | trichostrongylus vitrinus | vaccine | whipworm - trichuris ovis | black scour worm | clostridium perfringens type d | equine rotavirus | hair worm | intestinal

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - moxidectin; clostridium novyi type b - antisera/antigen; clostridium perfringens type d - antisera/antigen; blackleg = clostridium chauvoei; malignant oedema = clostridium septicum; cla = corynebacterium pseudotuberculosis ovis; tetanus = clostridium tetani - misc. vaccines or anti sera - moxidectin anthelmintic active 5.0 g/l; clostridium novyi type b - antisera/antigen vaccine active 3.5 iu/ml; clostridium perfringens type d - antisera/antigen vaccine active 5.0 iu/ml; blackleg = clostridium chauvoei vaccine-microbial active 0.0 undefined; malignant oedema = clostridium septicum vaccine-microbial active 2.5 iu/ml; cla = corynebacterium pseudotuberculosis ovis vaccine-microbial active 1.0 units/ml; tetanus = clostridium tetani vaccine-toxoid active 2.5 iu/ml - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm (also inhibited l4) | black disease | black scour worm - teladorsagia spp. | black scour worm - trichostrongylus spp. | blackleg | brown stomach worm - ostertagia lyrata | cheesy gland | cooperia curticei | cooperia oncophora | enterotoxaemia (pulpy kidney) | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - adult & l4 stages | large mouthed bowel worm | malignant oedema | nematodirus abnormalis | nematodirus battus | nematodirus filicollis | nodule worm - o. columbianum | ostertagia circumcincta | ostertagia trifurcata | sheep itch mite | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tetanus | thin necked intestinal worm | thin necked intestinal worm-n. spathiger | trichostrongylus rugatus | whipworm - trichuris ovis | clostridium perfringens type d | hair worm | intestinal hair worm | lymphadenitis | lymphangitis | psorobia ovis | small brown stomach worm | small hair worm | small intestinal

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - powder and solvent for solution for injection/infusion - alteplase 50 mg/vial - enzymes - acute myocardial infarction :actilyse is indicated for use in the management of acute myocardial infraction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms.acute massive pulmonary embolism with hemodynamic deprivation:actylise is indicated in the management of acute massive pulmonary embolism (pe) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatment of acute ischaemic stroke.treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). the treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. this treatment is restricted to a prescription by a specialist in neurology.

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - powder and solvent for solution for injection/infusion - alteplase 20 mg/vial - enzymes - acute myocardial infarction :actilyse is indicated for use in the management of acute myocardial infraction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms.acute massive pulmonary embolism with hemodynamic deprivation:actylise is indicated in the management of acute massive pulmonary embolism (pe) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatment of acute ischaemic stroke.treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). the treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. this treatment is restricted to a prescription by a specialist in neurology.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallaria maj - micrurus corallinus venom 30 [hp_x] in 1 ml - edema - fluid retention  formulated for associated symptoms such as skin discoloration, discomfort and swelling due to fluid retention. formulated for associated symptoms such as skin discoloration, discomfort and swelling due to fluid retention.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallar - micrurus corallinus venom 35 [hp_x] in 1 g - edema  formulated for symptoms associated with generalized or peripheral edema due to injury or various health conditions.       formulated for symptoms associated with generalized or peripheral edema due to injury or various health conditions.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallaria maj - micrurus corallinus venom 30 [hp_x] in 1 g - edema - fluid retention  formulated for associated symptoms such as skin discoloration, discomfort and swelling due to fluid retention. formulated for associated symptoms such as skin discoloration, discomfort and swelling due to fluid retention.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallar - micrurus corallinus venom 35 [hp_x] in 1 ml - edema  formulated for symptoms associated with generalized or peripheral edema due to injury or various health conditions.       formulated for symptoms associated with generalized or peripheral edema due to injury or various health conditions.

Australia - English - Department of Health (Therapeutic Goods Administration)

brand developers australia pty ltd - 30878 - stocking, antioedema, arm/leg - the sankom patent socks are clinically proven to combat vascular conditions such as deep vein thrombosis and varicose veins. they use active graduated targeted compression to help evacuate venous blood from the legs and improve blood circulation, increasing circulation efficiency and reducing discomfort, pain and heaviness due to circulation problems. prevents swelling, pain, edema and deep vein thrombosis or reduces their symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

health ascension investments pty ltd - 64088 - oedema osmotic pack - a non-invasive wrap and pack to be applied to the surface of the body at the site of oedema to remove retained fluid by osmosis. it is not intended to heal wounds. it consists of a pack filled with materials with a high osmotic potential (soda crystals) that is disposable and environmentally safe, and a wrap made from highly absorbent bamboo cotton material designed to hold the pack in place and to absorb excess fluid. the wrap is a reusable part of the device. the packs are not reusable and must be disposed of after use.